This is a preview of subscription content, log in via an institution to check access.
Notes
Costs (2019 values) included those for drugs and hospitalisation.
Reference
Zakiyah N, et al. Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared to Enalapril for Heart Failure Patients in Indonesia. ClinicoEconomics and Outcomes Research : 5 Oct 2021. Available from: URL: https://doi.org/10.2147/CEOR.S322740
Rights and permissions
About this article
Cite this article
Sacubitril/valsartan could be cost effective for patients with heart failure in Indonesia. PharmacoEcon Outcomes News 889, 26 (2021). https://doi.org/10.1007/s40274-021-08114-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08114-1